CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice
Xiaoqing Wang(Harvard University), Peng Qu(Second Affiliated Hospital of Dalian Medical University)
Cited by 17
Related Papers
Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient mice
|Experimental and Therapeutic Medicine|2021|24
PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy
|Frontiers in Pharmacology|2024|4
<i>In Vivo</i> CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy Target
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1